Utah Study Identifies Arc as Tau Spread Driver in Alzheimer’s, Opening 1 New Therapy Route
Updated
Updated · Inside Precision Medicine · Jun 26
Utah Study Identifies Arc as Tau Spread Driver in Alzheimer’s, Opening 1 New Therapy Route
3 articles · Updated · Inside Precision Medicine · Jun 26
Summary
Cell-published University of Utah Health research found the neuronal protein Arc helps toxic tau move from diseased neurons into neighboring healthy cells, a mechanism that could help explain how Alzheimer’s pathology advances through the brain.
Mouse experiments showed removing Arc made tau transfer between neurons almost disappear because Arc packages tau into extracellular vesicles that can seed new tau aggregation after entering recipient cells.
That mechanism comes with a tradeoff: without Arc, tau built up inside affected neurons and showed early toxicity, suggesting therapies may need to block tau-containing vesicles after release rather than simply shut down Arc.
Human postmortem brain samples also contained extracellular vesicles with both Arc and phosphorylated tau, and higher Arc levels tracked with higher phosphorylated tau, though the authors said the strongest causal evidence still comes from mice.
The findings point to a potential way to slow disease progression—not reverse existing damage—at a time when Alzheimer’s drug development is increasingly focused on modifying underlying biology beyond amyloid.
If the Arc protein spreads Alzheimer's but is vital for memory, can we block it without causing more harm?
With gut problems now predicting brain disease, could future Alzheimer's therapies begin with the digestive system?
Breakthrough Discovery: Arc Protein’s Role in Tau Propagation Offers New Hope for Alzheimer’s Treatment
Overview
A recent University of Utah Health study has revealed that the neuronal protein Arc is a key driver in the spread of tau protein, a hallmark of Alzheimer’s disease. Arc plays a dual role, both protecting neurons and helping tau to propagate by forming vesicles that contain both Arc and tau. These Arc-Tau vesicles move from diseased to healthy neurons, spreading toxic tau and contributing to cognitive decline. This discovery not only explains how tau spreads in the brain but also opens up promising new directions for developing therapies that could block this process and slow Alzheimer’s progression.